✦ LIBER ✦

An analysis of the presence of fc receptors on bone marrow lymphoblasts in acute lymphoblastic leukemia a pediatric oncology group study

✍ Scribed by G. Bennett Humphrey; Rebecca Blackstock; John M. Falletta; Richard S. Metzgar; Ellen R. Richie; D. Jeanette Pullen; James M. Boyett; Jonathan J. Shuster; Mary Ann Roper; Edward Clifford Russell; Donald H. Mahoney; Abdel H. Ragab

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 555 KB
Volume: 56
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19851015)56:8<1995::aid-cncr2820560818>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternating drug pairs with or without p

Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission : A Pediatric Oncology Group study

✍ George R. Buchanan; Gaston K. Rivera; Brad H. Pollock; James M. Boyett; Allen R. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Background: Children with acute lymphoblastic leukemia (all) who experience hematologic recurrence while receiving chemotherapy or within 6 months after its cessation have a low cure rate. in this study (pediatric oncology group protocol 8303) two methods were examined for improving the outcome

Impact of the timing of triple intrathec

Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: A pediatric oncology group study

✍ Hvizdala, Eva ;Berry, D. H. ;Chen, Timothy ;Dyment, Paul G. ;Kim, Tae H. ;Steube 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Five weekly doses of triple intrathecal (IT) chemotherapy (methotrexate, hydrocortisone, cytosine arabinoside) starting on day 1 of treatment were added to systemic induction therapy in a regimen (Arm 3) that was compared to three other regimens (Arms 1, 2, and 4) in which central nervous system (CN

Comparison of the cellularity and presen

Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at day 7–14 of chemotherapy

✍ Kidd, Pamela G.; Saminathan, Thamarai; Drachtman, Richard A.; Ettinger, Lawrence 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 23 KB 👁 3 views

Background. Many pediatric chemotherapy protocols for treatment of ALL require a bone marrow examination at day 7 or day 14 after initiation of therapy. The usefulness of a bone marrow biopsy, in addition to an aspirate, has been a frequently asked question. Procedure. This study addresses the eval

The low frequency of defective TPMT alle

The low frequency of defective TPMT alleles in Turkish population: A study on pediatric patients with acute lymphoblastic leukemia

✍ Tugba Boyunegmez Tumer; Gulen Ulusoy; Orhan Adali; Gurses Sahin; Sevgi Gozdasogl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract 6‐Mercaptopurine (6MP) is an essential anticancer drug used in the treatment of childhood acute lymphoblastic leukemia (ALL). Thiopurine methyltransferase (TPMT) polymorphisms are the major determinants of interindividual differences in the severe toxicity or efficacy of 6MP. Four varia

Bone marrow transplantation versus chemo

Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: A study of the children's cancer group (CCG-1884)

✍ Feig, Stephen A.; Harris, Richard E.; Sather, Harland N. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 3 views

Background. Maintenance of second remission of childhood acute lymphoblastic leukemia (ALL) with intensive chemotherapy is often unsuccessful. The major cause of treatment failure is relapse. Materials and Methods. Of 96 children with ALL who relapsed in the marrow while on or within 1 year of comp

Comparison of idarubicin to daunomycin i

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group

✍ Feig, Stephen A.; Ames, Matthew M.; Sather, Harland N.; Steinherz, Laurel; Reid, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1003 KB

The outcome of children with acute lymphoblastic leukemia (ALL) and bone marrow relapse has been unsatisfactory largely because of failure to prevent subsequent leukemia relapses. Ninety-six patients were enrolled and received vincristine, prednisone, L-asparaginase, and an anthracycline as reinduc